05/07/2025 8:10 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025 8:25 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2025 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/16/2025 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/11/2025 3:00 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
04/11/2025 3:00 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
04/07/2025 4:25 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 7:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2025 7:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2025 8:13 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for NRSN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
01/06/2025 9:40 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2024 3:47 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
12/23/2024 8:04 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2024 10:06 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 1:42 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
12/12/2024 4:08 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/04/2024 7:32 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024 3:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/24/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
11/22/2024 3:30 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
10/31/2024 3:59 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 8:45 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 7:35 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024 7:30 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 8:35 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024 8:13 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
10/01/2024 5:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
09/30/2024 3:53 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024 8:25 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 5:10 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024 5:10 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024 4:00 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/28/2024 6:05 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024 7:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 8:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 8:24 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/09/2024 8:29 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2024 8:11 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
The “80/20” stock calendar (Ad) Imagine having a “trading calendar” with what could be the EXACT dates to buy and sell some of your favorite stocks…
I’m talking about popular stocks like Apple, Walmart and even Google!
Imagine being able to hone in on the only days of the year that our backtesting has found are historically shown to yield the BIGGEST opportunities...
With these unique sheets in your hands, designed to help you decide when to confidently enter AND exit trades...
Sounds crazy?
The crazy thing is that this ability exists RIGHT NOW.  You can see what I mean when you click right here |
07/01/2024 7:05 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 7:20 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/27/2024 7:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 7:16 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/24/2024 8:20 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:42 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 4:24 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/17/2024 4:25 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/17/2024 4:22 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 6:14 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |